{"nct_id":"NCT01725100","title":"A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2013-02-05","start_date_type":"ACTUAL","primary_completion_date":"2015-01-30","primary_completion_date_type":"ACTUAL","completion_date":"2015-01-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}